PNT - POINT Biopharma Global Inc.
IEX Last Trade
12.51
12.510 100.000%
Share volume: 0
Last Updated: Tue 26 Dec 2023 09:07:44 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
26%
Profitability
35%
Dept financing
3%
Liquidity
75%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-0.28%
Return on assets
-0.32%
Return on sales
-266.81%
Return on invested capital
-218.45%
Total debt ratio
10%
Debt ratio change over timeo
-1.12%
Current Ratio
11.42%
Quick Ratio
11.42%
Cash Position Ratio
11.2%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.14%
Return on assets
3.79%
Return on sales
-266.81%
Return on invested capital
-208.5%
Total debt ratio
11.63%
Debt ratio change over timeo
-1.16%
Current Ratio
10.15%
Quick Ratio
10.15%
Cash Position Ratio
9.99%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
-5.68%
Return on assets
-6.33%
Return on sales
-647.35%
Return on invested capital
-104.81%
Total debt ratio
10.11%
Debt ratio change over time
-1.04%
Current Ratio
10.51%
Quick Ratio
10.51%
Cash Position Ratio
10.28%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-112.87%
Return on assets
-112.65%
Return on sales
-14.37%
Return on invested capital
192.6%
Total debt ratio
-111.78%
Debt ratio change over time
-1.12%
Current Ratio
-8.48%
Quick Ratio
-8.48%
Cash Position Ratio
-8.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PNT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -0.28% | 0% | 0% | -106.57% |
| Return on assets | -0.32% | 0% | 0% | -12.17% |
| Return on sales | -266.81% | 0% | 0% | -8133.27% |
| Return on invested capital | -218.45% | 0% | 0% | -41.1% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 10% | 0% | 0% | 80.46% |
| Debt ratio change over time | -1.12% | 0% | 0% | -0.75% |
| Dept financing | 3% | 0% | 25% | 25% |
| Current Ratio | 10.15% | 0% | 0% | 6.21% |
| Quick Ratio | 10.15% | 0% | 0% | 6.2% |
| Cash Position Ratio | 9.99% | 0% | 0% | 5.92% |
| Liquididy | 75% | 0% | 0% | 50% |
| Short-term ratios | PNT | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 4.14% | 0% | 0% | -327.32% |
| Return on assets | 3.79% | 0% | 0% | -17.01% |
| Return on sales | -266.81% | 0% | 0% | -23351.25% |
| Return on invested capital | -208.5% | 0% | 0% | -301.3% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 11.63% | 0% | 0% | 105.86% |
| Debt ratio change over time | -1.16% | 0% | 0% | -1.68% |
| Dept financing | 3% | 0% | 25% | 25% |
| Current Ratio | 10.15% | 0% | 0% | 6.21% |
| Quick Ratio | 10.15% | 0% | 0% | 6.2% |
| Cash Position Ratio | 9.99% | 0% | 0% | 5.92% |
| Liquididy | 75% | 0% | 0% | 45% |